Aviva PLC boosted its holdings in Clorox Co (NYSE:CLX) by 13.2% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 64,706 shares of the company’s stock after purchasing an additional 7,545 shares during the quarter. Aviva PLC’s holdings in Clorox were worth $11,210,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other hedge funds and other institutional investors have also added to or reduced their stakes in CLX. Marshall Wace North America L.P. acquired a new position in shares of Clorox during the 1st quarter valued at about $65,000. Orser Capital Management LLC grew its holdings in Clorox by 6.0% in the fourth quarter. Orser Capital Management LLC now owns 12,010 shares of the company’s stock valued at $1,836,000 after purchasing an additional 675 shares during the period. Russell Investments Group Ltd. increased its position in Clorox by 49.0% during the fourth quarter. Russell Investments Group Ltd. now owns 49,768 shares of the company’s stock worth $7,619,000 after purchasing an additional 16,367 shares during the last quarter. Cambridge Investment Research Advisors Inc. raised its stake in Clorox by 6.4% during the fourth quarter. Cambridge Investment Research Advisors Inc. now owns 29,300 shares of the company’s stock worth $4,499,000 after purchasing an additional 1,770 shares during the period. Finally, Mitsubishi UFJ Kokusai Asset Management Co. Ltd. boosted its holdings in shares of Clorox by 8.3% in the 4th quarter. Mitsubishi UFJ Kokusai Asset Management Co. Ltd. now owns 58,774 shares of the company’s stock valued at $8,987,000 after purchasing an additional 4,517 shares during the last quarter. Hedge funds and other institutional investors own 78.75% of the company’s stock.
In other news, CFO Kevin B. Jacobsen sold 15,066 shares of the stock in a transaction on Wednesday, May 13th. The stock was sold at an average price of $206.59, for a total value of $3,112,484.94. Following the completion of the transaction, the chief financial officer now owns 21,452 shares of the company’s stock, valued at $4,431,768.68. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, SVP Denise Garner sold 25,832 shares of the firm’s stock in a transaction on Monday, June 8th. The shares were sold at an average price of $197.62, for a total value of $5,104,919.84. Following the transaction, the senior vice president now directly owns 17,468 shares in the company, valued at $3,452,026.16. The disclosure for this sale can be found here. Insiders sold 73,011 shares of company stock worth $14,788,606 over the last quarter. 1.14% of the stock is currently owned by company insiders.
CLX has been the topic of several research reports. Cfra increased their target price on Clorox from $170.00 to $190.00 and gave the stock a “hold” rating in a research report on Friday, May 1st. Royal Bank of Canada reaffirmed a “hold” rating and set a $195.00 price target on shares of Clorox in a research report on Tuesday, April 14th. Barclays reissued a “sell” rating and issued a $164.00 price objective on shares of Clorox in a research report on Tuesday, May 5th. Argus raised Clorox from a “hold” rating to a “buy” rating and set a $195.00 target price for the company in a research report on Monday, March 9th. Finally, Morgan Stanley raised their target price on Clorox from $173.00 to $177.00 and gave the company an “underweight” rating in a report on Monday, May 4th. Three analysts have rated the stock with a sell rating, nine have assigned a hold rating and two have assigned a buy rating to the stock. The company presently has a consensus rating of “Hold” and an average price target of $173.62.
Clorox stock traded down $1.07 during mid-day trading on Thursday, reaching $206.23. The company’s stock had a trading volume of 78,505 shares, compared to its average volume of 2,084,661. Clorox Co has a twelve month low of $144.12 and a twelve month high of $214.26. The business has a 50 day moving average price of $199.36 and a 200-day moving average price of $172.32. The company has a current ratio of 0.98, a quick ratio of 0.72 and a debt-to-equity ratio of 3.69. The firm has a market cap of $26.30 billion, a price-to-earnings ratio of 30.62, a PEG ratio of 4.97 and a beta of 0.27.
Clorox (NYSE:CLX) last issued its earnings results on Friday, May 1st. The company reported $1.89 EPS for the quarter, beating the Zacks’ consensus estimate of $1.72 by $0.17. The company had revenue of $1.78 billion during the quarter, compared to the consensus estimate of $1.69 billion. Clorox had a return on equity of 147.52% and a net margin of 13.67%. Clorox’s quarterly revenue was up 15.0% compared to the same quarter last year. During the same period in the previous year, the firm posted $1.44 earnings per share. On average, equities analysts expect that Clorox Co will post 6.89 EPS for the current fiscal year.
The business also recently announced a quarterly dividend, which will be paid on Friday, August 14th. Shareholders of record on Wednesday, July 29th will be given a $1.11 dividend. The ex-dividend date of this dividend is Tuesday, July 28th. This is a positive change from Clorox’s previous quarterly dividend of $1.06. This represents a $4.44 annualized dividend and a yield of 2.15%. Clorox’s dividend payout ratio (DPR) is currently 67.09%.
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Cleaning, Household, Lifestyle, and International. The company offers laundry additives, including bleach products under the Clorox brand, as well as Clorox 2 stain fighter and color booster; home care products primarily under the Clorox, Formula 409, Liquid-Plumr, Pine-Sol, S.O.S, and Tilex brands; naturally derived products under the Green Works brand; and professional cleaning, disinfecting, and food service products under the Clorox, Dispatch, HealthLink, Clorox Healthcare, Hidden Valley, KC Masterpiece, and Soy Vay brands.
Featured Article: Is it better to buy a fund with a higher or lower NAV?
Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Clorox Co (NYSE:CLX).
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.